Risedronate (risedronate): Reviews and patient testimonials
Medication indications
Risedronate sodium 30 mg film-coated tablets
Treatment of Paget's disease of the bone.
Risedronate sodium 35 mg film-coated tablets
Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures.
Treatment of osteoporosis in men at high risk of fractures.
Risedronate Sodium 35 mg Film-coated Tablets
Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures. Treatment of osteoporosis in men at high risk of fractures.(see section 5.1).Risedronate sodium 5 mg film-coated tablets
Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis.
To maintain or increase bone mass in postmenopausal women undergoing long-term (more than 3 months), systemic corticosteroid treatment at doses ≥7.5mg/day prednisone or equivalent.
Route of administration: Oral
Molecule: risedronate
Patients' opinions on Risedronate
In brief
General satisfaction level: 7.25/10 Learn more
Treatment's effectiveness: 7.00/10 Learn more
Ease of use: 7.75/10 Learn more
Adherence to prescription: 8.25/10 Learn more
Detected side effects: 6.50/10 Learn more
Improvement in the quality of life: 7.00/10 Learn more
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community